What is NAGE's common stock, shares authorized (in shares)?

NAGE (NAGE) reported common stock, shares authorized (in shares) of $150M in Q1 2026.

How has NAGE's common stock, shares authorized (in shares) changed year-over-year?

NAGE's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $150M to $150M.

What is the long-term trend for NAGE's common stock, shares authorized (in shares)?

Over 3 years (2022 to 2025), NAGE's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $150M to $150M.

NAGE NAGE Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Nature's Sunshine ProductsNATR

——

eXoZymes Inc. Common StockEXOZ

——

Lifevantage CorporationLFVN

——

NuSkin EnterprisesNUS

——

USANA Health SciencesUSNA

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Balance sheet

See full

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Cash flow

See full

Operating cash flow-$1.2M-115%

Valuation

See full

Market cap$254.07M-74.9%

Enterprise value$190.09M-79.7%

P/E13.6×-43.5×

P/S2×-6.8×

Profitability

See full

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Returns & leverage

See full

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NAGE's common stock, shares authorized (in shares)?: NAGE (NAGE) reported common stock, shares authorized (in shares) of $150M in Q1 2026.
How has NAGE's common stock, shares authorized (in shares) changed year-over-year?: NAGE's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $150M to $150M.
What is the long-term trend for NAGE's common stock, shares authorized (in shares)?: Over 3 years (2022 to 2025), NAGE's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $150M to $150M.